Peer Review Process

Peer Review Process

The Tamil Nadu Journal of Pharmaceutical Research (TNJPR) follows a rigorous double-blind peer review process to ensure the quality, originality, and scientific validity of all published work.

1. Initial Editorial Screening

Upon submission, manuscripts are first assessed by the editorial office for completeness, adherence to the journal's Author Guidelines, and basic scope suitability. Manuscripts that do not meet these requirements, or that fall outside the journal's scope, may be returned to the author or rejected without external review. All submissions are also screened for plagiarism using similarity-detection software.

2. Assignment to Reviewers

Manuscripts that pass initial screening are assigned by the Editor-in-Chief or a Section Editor to a minimum of two independent reviewers with relevant subject expertise. The review process is double-blind: author identities are withheld from reviewers, and reviewer identities are withheld from authors, to minimize bias.

3. Review Criteria

Reviewers evaluate manuscripts on the basis of:

  • Originality and significance of the research
  • Scientific soundness of methodology
  • Validity and clarity of results and interpretation
  • Appropriateness and completeness of references
  • Overall clarity, organization, and adherence to journal format
  • Compliance with ethical standards for research involving humans, animals, or sensitive data

4. Editorial Decision

Based on reviewer recommendations, the Editor-in-Chief makes one of the following decisions:

  • Accept – The manuscript is accepted as submitted.
  • Minor Revision – The manuscript requires small changes before acceptance.
  • Major Revision – The manuscript requires substantial revision and will typically undergo a further round of review.
  • Reject – The manuscript is not suitable for publication in TNJPR.

5. Timeline

TNJPR aims to provide an initial editorial decision within 4–6 weeks of submission. Authors submitting revisions are typically asked to return their revised manuscript within [insert timeframe, e.g., 3–4 weeks] to avoid delays in processing.

6. Appeals

Authors who disagree with an editorial decision may submit a formal appeal to the Editor-in-Chief, explaining the grounds for reconsideration. Appeals are evaluated on a case-by-case basis and may be referred to an independent reviewer or editor for a final decision.

7. Confidentiality

All manuscripts under review are treated as confidential documents. Reviewers and editors are required to maintain the confidentiality of the review process and must not use unpublished information from a manuscript for their own research purposes without the authors' explicit written consent.